Properties of 8,9-dichloro-2,3,4,5-tetrahydro-1H-2-benzazepine, an inhibitor of norepinephrine N-methyltransferase.
D000311:Adrenal Glands / Q000201:enzymology; D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects; D001552:Benzazepines / Q000494:pharmacology*; D001596:Benzylamines / Q000494:pharmacology; D001921:Brain / Q000201:enzymology; D066298:In Vitro Techniques; D007546:Isoquinolines / Q000494:pharmacology; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D010625:Phenylethanolamine N-Methyltransferase / Q000037:antagonists & inhibitors*; D011817:Rabbits; D051381:Rats; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects; D044005:Tetrahydroisoquinolines
D001552:Benzazepines; D001596:Benzylamines; D007546:Isoquinolines; D011942:Receptors, Adrenergic, alpha; D044005:Tetrahydroisoquinolines; C002569:2,3-dichloro-alpha-methylbenzylamine; C028625:LY 134046; C012153:7,8-dichloro-1,2,3,4-tetrahydroisoquinoline; D010625:Phenylethanolamine N-Methyltransferase